Skip to main content
logo
MindBio Therapeutics Corp. (CSE:MBIO)
Canada flag Canada · Delayed Price · Currency is CAD
0.2450
0.00 (0.00%)
At close: Sep 3, 2026

MindBio Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
2359-
Market Cap Growth
-47.89%-46.64%-42.86%--
Enterprise Value
4710--
Last Close Price
0.242.0016.0028.00-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22
PB Ratio
-1.40-1.30-1.08-1.95-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
-1.68-0.92-0.92-0.92-1.06
Net Debt / Equity Ratio
-1.63-0.89-0.89-0.86-0.74
Net Debt / EBITDA Ratio
-0.30-1.22---0.59
Quick Ratio
0.470.050.040.131.17
Current Ratio
0.470.050.040.231.35
Return on Assets (ROA)
-718.60%-764.50%-91.41%-175.93%-
Return on Capital Employed (ROCE)
537.30%77.80%12.40%142.90%-1284.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-382.22%-88.39%-7.05%-40.57%-
Buyback Yield / Dilution
-1984.96%-54.23%-20.80%-106.14%-